文献速递糖尿病

种族和民族多样化的儿童人群中青少年的成人起病型糖尿病(MODY)

Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究回顾性分析了美国西南部大型学术儿童医院中50例经基因确诊的MODY患儿电子病历,发现非西班牙裔白人以外的种族/民族、无父母糖尿病史、诊断时超重/肥胖、血脂异常和/或高血压及黑棘皮症分别占52%、24%、22.2%、30%和12%,8%的GCK-MODY病例胰岛抗体阳性。HNF4A-MODY、HNF1A-MODY和HNF1B-MODY诊断时平均糖化血红蛋白高于GCK-MODY(7.0%、6.7%、6.7% vs 6.1%,P=0.005)。结论认为现行考虑MODY诊断的指南可能不适用于种族/民族多样化的美国糖尿病儿童人群。

要点

  • 52%的MODY病例为非西班牙裔白人以外的种族/民族,24%无父母糖尿病史。
  • 22.2%诊断时超重/肥胖,30%有血脂异常和/或高血压,12%有黑棘皮症。
  • 8%的GCK-MODY病例胰岛抗体阳性;HNF4A/HNF1A/HNF1B-MODY诊断时平均HbA1c高于GCK-MODY(P=0.005)。

核心结论

  • 现行考虑MODY诊断的指南可能不适用于种族/民族多样化的美国糖尿病儿童人群。

研究设计与样本

  • 回顾性病例复习,纳入美国西南部一家大型学术儿童医院中经分子诊断确诊MODY的50例糖尿病患儿。

主要发现

  • 50例基因确诊MODY中,GCK-MODY(MODY2)占60%(n=30),HNF1A-MODY(MODY3)占16%(n=8),HNF1B-MODY(MODY5)占18%(n=9),HNF4A-MODY(MODY1)占4%(n=2),2%为多个MODY基因变异导致的双重分子诊断(n=1)。
  • 非西班牙裔白人以外的种族/民族占52%(n=26),无父母糖尿病史占24%(n=12),诊断时超重/肥胖占22.2%(n=11),血脂异常和/或高血压占30%(n=15),体格检查记录黑棘皮症占12%(n=6)。
  • 8%的GCK-MODY病例胰岛抗体阳性(n=4)。
  • 诊断时平均糖化血红蛋白在HNF4A-MODY为7.0%、HNF1A-MODY为6.7%、HNF1B-MODY为6.7%,高于GCK-MODY的6.1%(P=0.005)。
  • 4例(13.3%)GCK-MODY患者有持续蛋白尿或原因不明的神经病变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Current practice guidelines recommend considering a diagnosis of maturity-onset diabetes of the young (MODY) in patients with diabetes with an affected parent but without typical features of type 1 or type 2 diabetes. OBJECTIVE: To test if these criteria apply to a real-world cohort of racially/ethnically diverse children with diabetes. METHODS: We performed a retrospective case review of electronic medical records of youth diagnosed with MODY in a large academic pediatric hospital in Southwestern United States. Cases were ascertained based on the identification of a molecular diagnosis of MODY. RESULTS: We studied 50 genetically confirmed cases of MODY: 60% GCK-MODY (MODY2, n = 30), 16% HNF1A-MODY (MODY3, n = 8), 18% HNF1B-MODY (MODY5, n = 9), 4% HNF4A-MODY (MODY1, n = 2), and 2% with a dual molecular diagnosis resulting from variants in more than one MODY gene (n = 1). Race/ethnicity other than non-Hispanic White, lack of parental diabetes history, obesity/overweight at diagnosis, dyslipidemia and/or hypertension and acanthosis nigricans documented on physical examination were observed, respectively, in 52% (n = 26), 24% (n = 12), 22.2% (n = 11), 30% (n = 15), and 12% (n = 6) of MODY cases. Furthermore, islet antibody positivity was observed in 8% of the cases GCK-MODY (n = 4). The mean hemoglobin A1c at diabetes diagnosis was higher in patients with HNF4A-MODY (7.0%), HNF1A-MODY (6.7%), and HNF1B-MODY (6.7%), than in those with GCK-MODY (6.1%, P = 0.005). Four (13.3%) GCK-MODY patients had persistent proteinuria or neuropathy of undetermined cause. CONCLUSION: The current guidelines to consider a diagnosis of MODY may not apply to a racially/ethnically diverse US population of children with diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Relan S, Alarcon G, Guffey D, et al. Maturity-Onset Diabetes of the Young (MODY) in a Racially/Ethnically Diverse Pediatric Population. J Clin Endocrinol Metab. 2026. PMID: 40554608. doi:10.1210/clinem/dgaf360

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。